Prolidase activity in serum and pleural fluids in patients with tuberculous pleural effussion

Clinical Biochemistry

Volumn 41, Issue 9, 2008, Pages 670-675

  Ipcioglu, Osman Metin ^a   Ozcan, Omer ^a   Gultepe, Mustafa ^a   Deniz, Omer ^b   Akgul, Emin Ozgur ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Pleurisy; Prolidase; Tuberculosis

Indexed keywords

COLLAGEN; CYTOKINE; PROLINE DIPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MESOTHELIUM; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; TUBERCULOUS PLEURISY;

ADULT; COLLAGEN; DIPEPTIDASES; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; TUBERCULOSIS, PLEURAL;

EID: 43449110905     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.03.006     Document Type: Article

References (51)

1. Global tuberculosis control. WHO Rep. 21 (2003)
2. Raviglione M., and Luelmo F. Update on the global epidemiology of TB. Curr. Issues Public Health 2 (1996) 192-197
3. Promkiamon B. Comparison of various diagnostic tests in tuberculous pleuritis. Thorac. Soc. Thail. Newsl. 6 (1997) 5
4. Maartens G., and Bateman E.D. Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax 46 (1991) 96-99
5. Aoki Y., Katoh O., Nakanishi Y., Kuroki S., and Yamada H. Comparison study of IFN-γ, ADA, and CA125 as the diagnostic parameters in tuberculous pleuritis. Respir. Med. 88 (1994) 139-143
6. Valdes L., San Jose E., Alvarez D., Sarandeses A., Pose A., and Chomon B. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 103 (1993) 458-465
7. Lin F.C., Chen Y.C., Chen F.J., and Chang S.C. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clin. Immunol. 116 2 (2005) 166-173
8. Myara I., Charpentier C., and Lemonnier A. Prolidase and prolidase deficiency. Life Sci. 34 (1984) 1985-1998
9. Mock W.L., Green P.C., and Boyer K.D. Specificity and pH dependence for acylproline cleavage by prolidase. J. Biol. Chem. 265 (1990) 19600-19605
10. Chamson A., Voigtlander V., Myara I., and Frey J. Collagen biosynthetic anomalies in prolidase deficiency: effect of glycyl-l-proline on the degradation of newly synthesized collagen. Clin. Physiol. Biochem. 7 (1989) 128-136
11. Muszynska A., Pałka J., and Gorodkiewicz E. The mechanism of daunorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis. Exp. Toxicol. Pathol. 52 (2000) 149-155
12. Emmerson K.S., and Phang J.M. Hydrolysis of proline dipeptides completely fulfills the proline requirement in a proline - auxotropic Chinese hamster ovary cell line. J. Nutr. 123 (1993) 909-914
13. Kurien B.T., Patel N.C., Porter A.C., D'Souza A., Miller D., and Matsumoto H. Prolidase deficiency and biochemical assays used in its diagnosis. Anal. Biochem. 349 (2006) 165-175
14. Jackson S.H., Dennis A.W., and Greenberg M. Iminopeptiduria: a genetic defect in recycling of collagen; a method for determining prolidase in erythrocytes. CMA J. 113 (1975) 759-763
15. Miltyk W., Karna E., and Pałka J. Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts. Pol. J. Pharmacol. 48 (1996) 609-613
16. Pałka J., Miltyk W., Karna E., and Wołczyński S. Modulation of prolidase activity during in vitro aging of human skin fibroblasts the role of extracellular matrix collagen. Tokai J. Exp. Clin. Med. 21 (1996) 207-213
17. Miltyk W., and Pałka J.A. Potential role of pyrroline 5-carboxylate in regulation of collagen biosynthesis in cultured human skin fibroblasts. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 125 (2000) 265-271
18. Wong P.C. Management of tuberculous pleuritis: can we do better?. Respirology 10 2 (2005 Mar) 144-148
19. Okamoto M., Imai{dotless}zumi{dotless} K., Hasegawa Y., Hashi{dotless}moto N., Sumi{dotless}da A., Shi{dotless}bazaki{dotless} M., Takagi{dotless} K., Shi{dotless}mokata K., and Kawabe T. Macrophage-derived chemokine in malignant and tuberculous pleural effusions. Respirology 12 (2007) 581-584
20. Valdes L., Pose A., San Jose E., and Vazquez J.M.M. Tuberculous pleural effusions. Eur. J. Intern. Med. 14 (2003) 77-88
21. Chinard P. Photometric determination of proline and ornitine. J. Biol. Chem. 199 (1952) 61-65
22. Gultepe M., Ozcan O., Bolat B., Kayadibi H., and Ipci{dotless}oglu O.M. Measured prolidase activity versus physiological activity of the enzyme: inhibitory effect of proline. FEBS J. 273 Suppl.1 (2006) 75
23. Ravinlione M.C., Snider D.E., and Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 273 (1995) 220-226
24. Celik G., Kaya A., Poyraz B., Ciledag A., Elhan A.H., Oktem A., Tozkoparan E., and Ozkan M. Diagnostic value of leptin in tuberculous pleural effusions. Int. J. Clin. Pract. 60 11 (2006) 1437-1442
25. Cakir E., Deniz O., Ozcan O., Tozkoparan E., Yaman H., Akgul E.O., Bilgi C., Bilgic H., Ekiz K., and Erbil M.K. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy. Clin. Biochem. 38 3 (2005) 234-238
26. Light R. Tuberculous pleural effusions. In: Redford D.C. (Ed). Pleural Disease. 3rd edn (1995), Williams & Wilkins, Baltimore 154-166
27. Frank W. Tuberculous pleural effusions. Eur. Respir. Monogr. 22 (2002) 219-233
28. Yamada Y., Nakamura A., and Hosoda M. Cytokines in pleural liquid for diagnosis of tuberculosis pleurisy. Respir. Med. 95 (2001) 577-581
29. Herbert A. Pathogenesis of pleurisy, pleural fibrosis and mesothelial proliferation. Thorax 41 (1986) 176-189
30. Barrett N.R. The pleura, with special reference to fibrothorax. Thorax 25 (1970) 515-524
31. Light R.W. Pleural Diseases. 4th edR (2001), Lippincort Willians and Wilkins, Philadelphia, PA 151-181
32. Light R.W. Pleural Diseases. 4th edR (2001), Lippincort Willians and Wilkins, Philadelphia, PA 182-195
33. Idell S., Girard W., Koenig K.B., Mclarty J., and Fair D.S. Abnormalities of pathways of fibrin turnover in the human pleural space. Am. Rev. Respir. Dis. 144 (1991) 187-194
34. Idell S., Zwieb C., Kumar A., Koenig K.B., and Johnson A.R. Pathway of fibrin turnover of human pleural mesothelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 7 (1992) 414-426
35. Whawell S.A., and Thompson J.N. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur. J. Surg. 161 (1995) 315-317
36. Whawell S.A., Scott-Coombes D.M., Vipond M.N., Tebbutt S.J., and Thompson J.N. Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells. Br. J. Surg 81 (1994) 214-216
37. Van Hinsbergh V.W.M., Kooistra T., Van den Berg E.A., Princen H.M.G., Fiers W., and Emeis J.J. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 72 (1988) 1467-1473
38. Fujino S., Yokoyama A., Kohno N., and Hiwada K. Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 14 (1996) 508-515
39. Antony V.B., Hott J.W., Kunkel S.L., Godbey S.W., Burdick M.D., and Strieter R.M. Pleural mesothelial cell expression of C-C (monocytechemotactic peptide) and C-X-C (interleukin 8) chemokines. Am. J. Respir. Cell Mol. Biol 12 (1995) 581-588
40. Antony V.B. Immunologic mechanisms in pleural disease. Eur. Respir. J. 21 (2003) 539-544
41. Hua C.C., Chang L.C., Chen Y.C., and Chang S.C. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 116 (1999) 1292-1296
42. de Pablo A., Villena V., Echave-Sustaeta J., and Encuentra A.L. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis?. Chest 112 (1997) 1293-1297
43. Surazynski A., Palka J., and Wolczynski S. Phosphorylation of prolidase increases the enzyme activity. Mol. Cell. Biochem. 220 (2001) 95-101
44. Palka J.A., and Phang J.M. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J. Cell. Biochem. 67 (1997) 166-175
45. Surazynski A., Sienkiewicz P., Wolczynski S., and Palka J. Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication in beta1-integrinmediated signaling. Pharmacol. Res. 51 (2005) 217-221
46. Palka J.A., Karna E., and Miltyk W. Fibroblast chemotaxis and prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate. Mol. Cell. Biochem. 168 (1997) 177-183
47. Senboshi Y., Oono T., and Arata J. Localization of prolidase gene expression in scar tissue using in situ hybridization. J. Dermatol. Sci. 12 (1996) 163-171
48. Myara I., Myara A., Mangeot M., Fabre M., Charpentier C., and Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin. Chem. 30 (1984) 211-215
49. Erbagci A.B., Araz M., Erbagci A., Tarakcioglu M., and Namiduru E.S. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin. Biochem. 35 (2002) 263-268
50. Altindag O., Erel O., Aksoy N., Selek S., Celik H., and Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol. Int. 27 (2007) 339-344
51. Gejyo F., Kishore B.K., and Arakawa M. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia. Nephron 35 (1983) 58-61